Adverse events and residual lesion rate after cold endoscopic mucosal resection of serrated lesions ≥10 mm
| Autor: | Noor Ezan Abdullah, Connor D. McWhinney, Douglas K. Rex, Ahmed El Rahyel, Krishna C. Vemulapalli |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Endoscopic Mucosal Resection medicine.medical_treatment Colonic Polyps Colonoscopy Endoscopic mucosal resection Lesion 03 medical and health sciences 0302 clinical medicine Humans Medicine Radiology Nuclear Medicine and imaging Adverse effect Retrospective Studies medicine.diagnostic_test business.industry Gastroenterology Confidence interval Polypectomy Endoscopy Hyperplastic Polyp 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Radiology medicine.symptom business |
| Zdroj: | Gastrointestinal Endoscopy. 93:654-659 |
| ISSN: | 0016-5107 |
| DOI: | 10.1016/j.gie.2020.08.032 |
| Popis: | Background and Aims Cold EMR is being increasingly used for large serrated lesions. We sought to measure residual lesion rates and adverse events after cold EMR of large serrated lesions. Methods In a single academic center, we retrospectively examined a database of serrated class lesions ≥10 mm removed with cold EMR for safety and efficacy. Results Five hundred sixty-six serrated lesions ≥10 mm in size were removed from 312 patients. We successfully contacted 223 patients (71.5%) with no reported serious adverse events that required hospitalization, repeat endoscopy, or transfusion. The residual lesion rate per lesion at first follow-up colonoscopy was 18 of 225 (8%; 95% confidence interval, 5-12.1). Lesions with residual were larger at polypectomy compared with lesions without recurrence (median, 23 mm versus 16 mm, P = .017). Conclusion Cold EMR appears to be safe and effective for the removal of large serrated lesions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect